BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35693548)

  • 1. Evaluation and Comparison of Mucormycosis Patients' Features Undergoing Functional Endoscopic Sinus Surgery Prior to and during the COVID-19 Pandemic: A Case-Control Study.
    Dehghanpisheh L; Eghbal M; Salari M; Shahriarirad R; Borzou N; Vatankhah P
    Int J Clin Pract; 2022; 2022():1248325. PubMed ID: 35693548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucor in a Viral Land: A Tale of Two Pathogens.
    Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
    Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.
    Kamath S; Kumar M; Sarkar N; Ahmed T; Sunder A
    Cureus; 2022 Jan; 14(1):e21054. PubMed ID: 35155019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hospitalization rate and clinical characteristics of mucormycosis prior and during COVID-19 pandemic: A single-center study.
    Estakhr M; Ghotbi Z; Rostamihosseinkhani M; Hooshmandi E; Janipour M; Ostovan VR; Fadakar N; Bazrafshan H; Bahrami Z; Rahimi-Jaberi A; Poursadeghfard M; Nazeri M; Kouhi P; Petramfar P; Izadi S; Barzegar Z; Nikzadeh E; Sasannia S; Arsang-Jang S; Tabrizi R; Khademi B; Kohandel-Shirazi M; Salehi MS; Ashjazadeh N; Khademi B; Ashraf MJ; Eilami O; Roudgari A; Moghaddami M; Zomorodian K; Badali H; Borhani-Haghighi A
    J Infect Dev Ctries; 2023 Jun; 17(6):791-799. PubMed ID: 37406065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinonasal mucormycosis during 2 years of COVID-19 pandemic in central Iran: incidence rate and clinical features.
    Dadgarnia M; Mandegari M; Baradaranfar M; Vaziribozorg S; Abdollahpour M
    Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(5):298-304. PubMed ID: 36966984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. As the virus sowed, the fungus reaped! A comparative analysis of the clinico-epidemiological characteristics of rhino-orbital mucormycosis before and during COVID-19 pandemic.
    Muraleedharan M; Panda NK; Angrish P; Arora K; Patro SK; Bansal S; Chakrabarti A; Rudramurthy SM; Bakshi J; Mohindra S; Gupta R; Virk RS; Verma RK; Ramavat AS; Nayak G
    Mycoses; 2022 May; 65(5):567-576. PubMed ID: 35289000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases.
    Özbek L; Topçu U; Manay M; Esen BH; Bektas SN; Aydın S; Özdemir B; Khostelidi SN; Klimko N; Cornely O; Zakhour J; Kanj SS; Seidel D; Hoenigl M; Ergönül Ö
    Clin Microbiol Infect; 2023 Jun; 29(6):722-731. PubMed ID: 36921716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series.
    Urias-Barreras CM; Rodríguez-Archilla A; Canizalez-Roman A; Bastidas DA; León-Sicairos NM
    J Stomatol Oral Maxillofac Surg; 2024 Feb; 125(1):101615. PubMed ID: 37648209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mucormycosis: retrospective evaluation of 12 cases].
    Arda B; Erdem A; Sipahi OR; Işıkgöz Taşbakan M; Pullukçu H; Taşbakan MS; Ceylan N; Metin DY; Midilli R; Yamazhan T; Ulusoy S
    Mikrobiyol Bul; 2011 Jul; 45(3):504-11. PubMed ID: 21935783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.
    Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P
    Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucormycosis, New Causative Agents, and New Susceptible Populations: Review of Cases in a Tertiary Care Hospital in Iran (2007-2021).
    Darazam IA; Babamahmoodi A; Ebrahimi MJ; Moafi M; Dilmaghani NA; Mardani M; Shokouhi S; Gharehbagh FJ; Chalmiani EM; Shabani M; Bidari F; Jamali E; Khoshsirat S; Shahriari M; Sabeti S; Rahmani Z; Mousavinejad SA; Ebrahimzadeh K; Hallajnejad M
    Iran J Public Health; 2023 Nov; 52(11):2467-2473. PubMed ID: 38106820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis.
    Yadav S; Bs N; Ak S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India.
    Meshram HS; Kute VB; Chauhan S; Dave R; Patel H; Banerjee S; Desai S; Kumar D; Navadiya V; Mishra V
    Int Urol Nephrol; 2022 Jul; 54(7):1693-1703. PubMed ID: 34792722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rise of the phoenix: Mucormycosis in COVID-19 times.
    Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
    Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucormycosis infection associated with global COVID-19 pandemic - an institutional histopathological study.
    Keerthika R; Narwal A; Kamboj M; Devi A; Anand R; N S; Singh V; Agarwal V; Gupta A
    Med Oral Patol Oral Cir Bucal; 2023 Mar; 28(2):e99-e107. PubMed ID: 36806020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucormycosis and COVID-19: An epidemic within a pandemic in India.
    Selarka L; Sharma S; Saini D; Sharma S; Batra A; Waghmare VT; Dileep P; Patel S; Shah M; Parikh T; Darji P; Patel A; Goswami G; Shah A; Shah S; Lathiya H; Shah M; Sharma P; Chopra S; Gupta A; Jain N; Khan E; Sharma VK; Sharma AK; Chan ACY; Ong JJY
    Mycoses; 2021 Oct; 64(10):1253-1260. PubMed ID: 34255907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Endoscopic Sinus Surgery and Recurrence of Post-COVID Mucormycosis.
    Rudagi BM; Goyal J; Palande C; Patil P
    J Maxillofac Oral Surg; 2022 Oct; ():1-8. PubMed ID: 36249584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.